Secret ties to industry and conflicting interests in cancer research

被引:44
作者
Hardell, Lennart [1 ]
Walker, Martin J.
Walhjalt, Bo
Friedman, Lee S.
Richter, Elihu D.
机构
[1] Univ Hosp Orebro, Dept Oncol, SE-70185 Orebro, Sweden
[2] Univ Orebro, Dept Nat Sci, Orebro, Sweden
[3] Slingshot Publicat, London, England
[4] Social Policy Res Inst, Skokie, IL USA
[5] Hebrew Univ Jerusalem, Hadassah Sch Community Med & Publ Hlth, Univ Occupat & Environm Med, Injury Prevent Ctr, IL-91120 Jerusalem, Israel
关键词
cancer research; conflicts of interest; consulting ethics; industry sponsors;
D O I
10.1002/ajim.20357
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Recently it was reported that a Swedish professor in environmental health has for decades worked as a consultant for Philip Morris without reporting his employment to his academic employer or declaring conflicts of interest in his research. The potential for distorting the epidemiological assessments of hazard and risk through paid consultants, pretending to be independent, is not exclusive to the tobacco industry Methods Documentation is drawn from peer reviewed publications, websites, documents from the Environmental Protection Agency, University reports, Wellcome Library Special Collections and the Washington Post. Results Some consulting firms employ university researchers for industry work thereby disguising industry links in the income of large departments. If the industry affiliation is concealed by the scientist, biases from conflicting interests in risk assessments cannot be evaluated and dealt with properly. Furthermore, there is reason to suspect that editors and journal staff may suppress publication of scientific results that are adverse to industry owing to internal conflict of interest between editorial integrity and business needs. Conclusions Examples of these problems from Sweden, UK, and USA are presented. The shortfalls cited in this article illustrate the need for improved transparency, regulations that will help curb abuses as well as instruments for control and enforcement against abuses. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 59 条
[1]  
ADAMI HO, 2001, ORGANOHALOGEN COMPOU, V54, P403
[2]  
ADAMI HO, 2000, DIOXIN CANC
[3]  
ADAMI HO, 1999, CANCER, V85, P1353
[4]  
[Anonymous], ORGANOHALOGEN COMP
[5]  
[Anonymous], ORGANOHAL COMP
[6]  
AXELSON O, 1986, REBUTTALS FINAL REPO
[7]  
BENNETT B, 1984, COMMUNICATION 1116
[8]  
BOICE JD, 2002, EPIDEMIOLOGICAL STUD
[9]  
Castleman BI, 2001, AM J IND MED, V39, P237, DOI 10.1002/1097-0274(200102)39:2<237::AID-AJIM1011>3.0.CO
[10]  
2-S